Highlights d Treatment with L. reuteri rescues social deficits in several ASD mouse models d L. reuteri reverses social deficits via the vagus nerve d L. reuteri reverses social deficits even in germ-free mice d OXTR inhibition prevents L. reuteri's effects on social behavior and VTA plasticity
INTRODUCTION
The prevalence of autism spectrum disorder (ASD), which is influenced by both genetic and environmental factors (Hallmayer et al., 2011; Kim and Leventhal, 2015) , continues to increase worldwide (Baio et al., 2018; Kawa et al., 2017) . However, effective treatments for ASD remain elusive. Defined as a heterogeneous neurodevelopmental disorder, ASD is characterized by social deficits, repetitive behaviors, and language difficulties (American Psychiatric Association, 2013) . In addition to these core symptoms, ASD patients are often afflicted with gastrointestinal (GI) issues (Holingue et al., 2018; McElhanon et al., 2014; . In fact, children with ASD are 3.5 times more likely to suffer from GI disorders than children without developmental disorders (Schieve et al., 2012) . Moreover, GI problems have been associated with changes in the microbial communities inhabiting the gut of ASD individuals (Ding et al., 2017; .
Studies in animal models have shown that gut microbes can modulate central nervous system (CNS)-driven behaviors in a very powerful way (Borre et al., 2014; Sharon et al., 2016; . Recently, in mice, we showed that maternal high-fat diet (MHFD) induces social deficits and a change in the gut microbiota of offspring that is characterized by a reduction of the commensal bacterial species L. reuteri . Consistent with these data, HFDinduced obesity in adult mice also leads to a reduction in the levels of L. reuteri (Sun et al., 2016) . More importantly, selective treatment with L. reuteri reverses the social deficits in MHFD offspring . However, whether L. reuteri can also rescue the social deficits of ASD models with different underlying etiologies remains unknown. Here, we first studied whether L. reuteri is able to reverse the social deficits in other mouse models of ASD. Surprisingly, we found that microbial treatment with this single bacterial species rescues the impaired social behavior in genetic, environmental, and idiopathic mouse models of ASD.
In addition, we sought to identify the mechanism by which a given bacterial strain (L. reuteri) regulates a selective behavior or disease state, which represents one of the most important challenges in microbiome research. More specifically, integrating multiple approaches, such as genetics, metagenomics, targeted vagotomies, immunohistochemistry, electrophysiology, and behavior, we began to dissect how L. reuteri impacts brain function. At the cellular and molecular levels, we provide new causal evidence that L. reuteri modulates social behavior and related changes in synaptic function within the social reward circuits via the oxytocinergic system. Moreover, at the systems level, we found that L. reuteri modulates social behavior independent of other microbes in the gut, and in a vagus nerve-dependent manner. Collectively, our findings provide new mechanistic insight into the gut-brain-axis signaling by which L. reuteri influences central nervous system function and selective behaviors. Figure 1 . Shank3B -/-Mice Exhibit Changes in Their Microbial Composition, Reduced L. reuteri Levels, and Social Deficits that Were Rescued by Treatment with L. reuteri (A) Principal coordinates analysis (PCoA) of unweighted UniFrac distances from the 16S rRNA gene-sequencing dataset shows that Shank3B À/À samples clustered separately from those of WT littermates (n = 6-7 per group; p < 0.01, R 2 = 0.225; 8,024 reads/sample).
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(B) qPCR analysis shows lower levels of L. reuteri in Shank3B À/À mice (as % of total bacteria, n = 9-16 per group; WT versus Shank3B À/À : Mann-Whitney test, p < 0.0001). (C) Schematic of experimental design. (D) Schematic of the three-chamber task. (E and F) In Shank3B À/À mice, L reuteri rescued social behavior deficits in the three-chamber test (E, Sociability, n = 7-13 per group; WT, t = 5.68, p < 0.0001; Shank3B À/À + vehicle, t = 0.14, p = 0.99; Shank3B À/À + L. reuteri, t = 8.066, p < 0.0001; twoway ANOVA, F 2,52 = 17.9, p < 0.0001; F, Social Novelty, n = 7-13 per group; WT, t = 5.01, p < 0.0001; Shank3B À/À + vehicle, t = 3.75, p < 0.01; Shank3B À/À + L. reuteri, t = 4.63, p < 0.0001; twoway ANOVA, F 2,52 = 0.52, p = 0.59). (G) Schematic of the reciprocal social interaction task. (H) L. reuteri rescued reciprocal social interaction deficits in Shank3B À/À mice (n = 9-12 pairs per group; WT versus Shank3B À/À + vehicle, t = 3.03, p < 0.05; Shank3B À/À + vehicle versus Shank3B À/À + L. reuteri, t = 3.20, p < 0.01; WT versus Shank3B À/À + L. reuteri, t = 0.32, p > 0.99; one-way ANOVA, F 2,28 = 6.3, p = 0.0055). ns, not significant. Plots show mean ± SEM. See also Figures S1-S5 and S15.
lacking the Shankb isoform of the Shank3 gene (Shank3B À/À mice) exhibit ASD-like behaviors, including social deficits (Peç a et al., 2011) . Given that individuals with ASD often show changes in their gut microbial ecology (Ding et al., 2017; , we wondered whether Shank3B À/À mice display alteration of their gut microbial composition. To answer this question, we performed 16S ribosomal RNA (rRNA) gene sequencing on fecal samples from Shank3B À/À mice and wild-type (WT) littermates, as previously described . Bacterial composition, computed based on weighted UniFrac distances (the assessment of community structure by considering abundance of operational taxonomic units, OTUs) or Shannon diversity index, was not significantly altered in Shank3B À/À mice compared to WT littermates (Figures S1A-S1D). By contrast, the bacterial diversity measured by unweighted UniFrac analysis, which assesses community structure by considering only the presence or absence of OTUs, revealed a significant difference in the phylogenetic profile of the microbial communities between genotypes ( Figure 1A) .
It is noteworthy that Shank3B À/À mice were obtained from heterozygous (Shank3B +/À ) breeding, as recommended for microbiome studies (Stappenbeck and Virgin, 2016) , ruling out potential differences in maternal care and/or early life effects of the gut microbiome. More importantly, we found that the microbiome changes depend on the genotype, but not on cage housing conditions (the so called ''cage effect''). For instance, WT mice clustered together regardless of their cage of origin (cage A, B, C, or D). The same is true for Shank3B À/À (KO) mice ( Figure S2 ).
Moreover, we found that Shank3B À/À mice specifically have lower levels of L. reuteri compared to their WT littermates (Figure 1B) . Thus, Shank3B À/À mice exhibit an altered gut microbial composition, including decreased L. reuteri levels in their gut.
Social deficits are one of the most salient features of individuals with ASD (American Psychiatric Association, 2013), and Shank3B À/À mice exhibit impaired social behavior (Peç a et al., 2011) . To examine whether reduced L. reuteri levels in the gut of Shank3B À/À mice could account for their social behavioral deficits, Shank3B À/À mice were treated with either vehicle or L. reuteri, added daily in drinking water for 4 weeks ( Figure 1C ). Social behaviors were first examined in the three-chamber sociability and social novelty tests, as we previously described . To test sociability, we compared the time that the experimental mouse spent interacting with either a stranger mouse (Mouse 1) or an empty wired cup (Empty, Figure 1D) . As expected, WT mice displayed normal sociability, as reflected by their preferential interaction with the stranger mouse. By contrast, Shank3B À/À mice showed no preference for the stranger mouse over the empty cup, indicating impaired sociability ( Figure 1E ). The social deficits in Shank3B À/À mice are not due to alterations in their olfactory ability, since olfaction was not impaired in these mice, as determined by the buried food test ( Figure S3A ). In addition, we found that, as in WT controls, Shank3B À/À mice displayed normal preference for social novelty, as they spent more time interacting with the novel mouse (Mouse 2) than with the familiar one (Mouse 1; Figure 1F ). Interestingly, we found that only one cohort of Shank3B heterozygous (Shank3B +/À ) mice showed impaired social behavior ( Figures S4A, S4C , and S4E). Thus, given the weak social behavior deficits in Shank3B +/À mice, we focused on the homozygous knockout line (Shank3B À/À mice), which consistently showed an impairment in sociability (Figures S4A, S4C, and S4E) .
Remarkably, treatment with L. reuteri rescued sociability in Shank3B À/À mice. Indeed, the performance of L. reuteri-treated Shank3B À/À mice was similar to that of WT controls ( Figure 1E ). To further support these findings, we next assessed reciprocal social interaction ( Figure 1G ) by measuring the amount of time that stranger, genotype-and treatment-matched mice spent interacting as pairs. Shank3B À/À mice interacted significantly less than WT littermates, and treatment with L. reuteri reversed the social deficits in the mutant mice ( Figure 1H ). It is noteworthy that Shank3B À/À mice are hypo-active, a condition that was not improved by L. reuteri ( Figure S5 ). Thus, treatment with L. reuteri selectively reverses the ASD-like social deficits in Shank3B À/À mice.
The VPA Mouse Model of ASD Shows Alterations in the Composition of the Gut Microbiota, and Treatment with L. reuteri Rescues Its Social Deficits Environmental factors may account for a large proportion of the ASD cases (Hallmayer et al., 2011) . In mammals, both pre-and post-natal periods are critical developmental windows ultimately influencing behavior during adulthood. During these early developmental periods, environmental factors can change the microbial composition of the host, and affect brain physiology and function via the so-called gut-microbiota-brain axis (Borre et al., 2014; Sharon et al., 2016; . For instance, among the environmental factors, maternal exposure to different nutrients (e.g., HFD) and/or substances (e.g., valproic acid, VPA) during pregnancy has been associated with ASD (Ornoy, 2009; Sullivan et al., 2014) . More specifically, clinical studies have shown that maternal exposure to VPA, a branched short-chain fatty acid used as an antiepileptic drug, is associated with increased risk of ASD incidence in offspring (Christensen et al., 2013; Ornoy, 2009) . Accordingly, in rodents, VPA administration during gestation leads to ASD-like behaviors (notably social deficits) in offspring (Kim et al., 2017) . Given that the MHFD environmental mouse model of ASD shows social deficits that are mediated by changes in the microbiome , we wondered whether the VPA mouse model of ASD is also characterized by alterations in their microbial ecology. Indeed, we found changes in the composition of the microbiota of VPA-treated mice ( Figures S6A-S6E ), but L. reuteri levels were not reduced in these mice ( Figure S6F ).
Given that (1) VPA alters oxytocin-mediated changes in synaptic transmission (Tyzio et al., 2014) , (2) intranasal oxytocin rescues social deficits in VPA-exposed mice (Hara et al., 2017) and other mouse models of ASD Peñ agarikano et al., 2015) , and (3) L. reuteri promotes oxytocin levels Poutahidis et al., 2013) , we next wondered whether treatment with L. reuteri would improve the social deficits in the offspring from VPA mice. Interestingly, unlike treatment with vehicle, treatment with L. reuteri ameliorates the social deficits in VPA mice (Figures S6G and S6H) . Taken together, these data demonstrate that, like in the MHFD model, L. reuteri also corrects the social deficits in another environmental model of ASD (VPA) with alterations in the gut microbiome.
BTBR Mice Show Alterations in the Composition of the Gut Microbiota, and Treatment with L. reuteri Rescues Their Social Deficits Several environmental and genetic factors have been identified to be associated with increased incidence of ASD (Hallmayer et al., 2011; Kim and Leventhal, 2015) . However, the majority of the ASD cases remain idiopathic. The BTBR T+ Itpr3tf/J (BTBR) inbred mouse line exhibits the core ASD symptoms, including abnormal social behavior (McFarlane et al., 2008; Scattoni et al., 2008) . Given that no genetic variants in ASD risk genes have been identified in the BTBR genome (Jones-Davis et al., 2013) , this model is considered an idiopathic model of ASD (Meyza and Blanchard, 2017) .
While previous studies have shown that BTBR mice harbor a different microbial community in the gut (Coretti et al., 2017; Golubeva et al., 2017) and cohousing with C57BL/6J mice has been shown to restore their social deficits (Yang et al., 2011) , the nature of the bacterial species which may be causally related to the social behavioral deficits in this ASD model remains unknown. Accordingly, we also found a markedly altered gut microbiome composition in BTBR mice compared to C57BL/6J mice (Figures 2A and S7 ). Moreover, we found a specific reduction in L. reuteri levels in BTBR mice ( Figure 2B ). Given that both Shank3B À/À and BTBR mice exhibit alterations in their gut microbial composition and decreased L. reuteri levels and that L. reuteri is sufficient to restore the social behavior in Shank3B À/À and VPA mice, we next wondered whether this selective microbial intervention would also be effective in BTBR mice. Indeed, treatment with L. reuteri improved the social deficits in the three chamber and reciprocal social interaction tasks in the BTBR mice ( Figures 2C-2E ). Similarly to the Shank3B À/À mice, social deficits in BTBR mice were not due to impaired olfaction (see Figure S3B ). Taken together, our data show that treatment with L. reuteri selectively reverses the ASD-like social deficits in genetic, environmental, and idiopathic models of ASD.
L. reuteri Rescues Social Deficits Independent of Other Gut Microbes
To dissect the mechanism(s) through which L. reuteri restores social behavior, we mainly focused on the Shank3B À/À model. We first asked whether L. reuteri exerts its effects on social behaviors directly, or indirectly by correcting the altered microbial composition of the host. To answer this question, we first analyzed the composition of the gut microbiota in vehicletreated and L. reuteri-treated Shank3B À/À mice, as determined by 16S rRNA gene sequencing. We found that treatment with L. reuteri did not significantly alter the microbial profile of either Shank3B À/À mice ( Figure 3A ) or BTBR mice ( Figure S8 ). Hence, L. reuteri has no significant impact in the overall microbial composition of the host.
To causally demonstrate whether the effects of L. reuteri on social behavior are dependent on its interaction with other members of the microbial community, mice raised under sterile conditions (i.e., germ-free [GF] mice) were monocolonized with L. reuteri at weaning, and social behavior was tested in 8-week-old mice. As previously described, unlike conventionally colonized mice, GF mice displayed social deficits Desbonnet et al., 2014) . Remarkably, monocolonization with L. reuteri was sufficient to reverse the social deficits in GF mice ( Figures 3B-3D ), supporting the notion that L. reuteri acts solo, rescuing social behavior in the absence of other members of the community.
L. reuteri Reverses Deficits in Social Behavior via the Vagus Nerve
It is widely accepted that there is a bidirectional gut-microbiotabrain axis, where bacteria initiate signals that are transmitted from the gut to the CNS, either through blood circulation or via the vagus nerve (Borre et al., 2014; Sharon et al., 2016; . If the integrity of the host's intestinal barrier is damaged and rendered more permeable (so-called ''leaky gut''), which occurs when the gut epithelium tight junctions are impaired (Suzuki, 2013) , bacteria and/or metabolites produced by bacteria can enter the blood circulation. Indeed, alterations in gut permeability have been described in individuals with ASD (Julio-Pieper et al., 2014; Mayer et al., 2014) . Thus, we first tested whether Shank3B À/À mice show increased intestinal permeability. To this end, we administered fluorescein isothocyanate-dextran (FITC-dextran) by oral gavage and measured its concentration in the serum, as described (Gupta and Nebreda, 2014) . If the intestinal barrier is compromised in Shank3B À/À mice, we would expect increased FITC-dextran in the serum of these mice. As expected, our positive control mice administrated with dextran sodium sulfate (DSS), a chemical which induces colitis, exhibited a leaky gut, as determined by increased FITC-dextran in their serum ( Figure 4A ). By contrast, compared to control littermates, Shank3B À/À mice showed no changes in gut permeability ( Figure 4A ). Accordingly, the expression of key tight junction proteins was not altered in Shank3B À/À mice, as determined by reverse transcription followed by quantitative PCR (RT-qPCR) ( Figure 4B ). Thus, Shank3B À/À mice did not show major alterations in gut permeability. We then investigated whether, for L. reuteri, the vagus nerve could serve as a channel of communication between the gut and the brain. Previous studies have shown that the vagus nerve is activated in response to specific bacteria (Perez-Burgos et al., 2014; Perez-Burgos et al., 2013) and that the Lactobacillus species L. rhamnosus reduces anxiety-related behavior in a vagusdependent manner (Bravo et al., 2011) . To determine whether the vagus nerve is required for L. reuteri to reverse the social deficits in Shank3B À/À mice, we performed bilateral subdiaphragmatic vagotomy in these mice ( Figure 4C ). Control mice (sham-operated mice) underwent the same surgical procedures, except that the vagal branches were not transected. If the vagus nerve is required for the relevant gut-microbiota-brain communication, L. reuteri should fail to rescue the social deficits in vagotomized Shank3B À/À mice. Consistent with this hypothesis, we found that L. reuteri rescued social behaviors in sham-operated, but not in vagotomized Shank3B À/À mice ( Figures 4D and 4F ). Results from several control experiments underscore the specificity of the vagotomy to the effects of L. reuteri on social behavior. First, the vagotomy was complete, as determined by a food intake analysis based on the satiating effect of cholecystokinin-octapeptide (CCK-8), which depends on the vagus nerve (Joyner et al., 1993;  Figure S9A ). Second, social behavior was similar in WT-sham and WT-vagotomized mice (Figures S9B-S9D). Moreover, preference for social novelty, which is not impaired in Shank3B À/À mice, was not affected by the vagotomy (Figure 4E ), indicating that the vagotomy itself had no effect on social behavior. Third, vagotomy did not affect motor behavior ( Figures S9E-S9H ). Finally, intranasal oxytocin-treatment, which bypasses the gut-microbiota-brain communication channel, restored social behaviors in vagotomized Shank3B À/À mice (see Figures 6D and 6E) , demonstrating that the vagotomy procedure did not prevent the animals' ability to perform the social task. Thus, L. reuteri reversed the social deficits in Shank3B À/À mice in a vagus nerve-dependent manner.
Oxytocin Rescues Social Behavioral Deficits in Genetic, Environmental, and Idiopathic Models of ASD Oxytocin modulates numerous aspects of social behaviors and is implicated in ASD (Donaldson and Young, 2008; LoParo and Waldman, 2015) . Treatment with oxytocin reverses social deficits in several mouse models of ASD Hara et al., 2017; Harony-Nicolas et al., 2017; Peñ agarikano et al., 2015) . Additionally, it is known that vagal nerve fibers project to the PVN (Sabatier et al., 2013; Uvn€ as-Moberg et al., 2015) , a brain region where oxytocin is produced, and that neuronal activity in the PVN induced by bacterial colonization is blocked by subdiaphragmatic vagotomy (Wang et al., 2002 stimulation of the vagus nerve can promote oxytocin release (Stock and Uvn€ as-Moberg, 1988) . We and others have shown that L. reuteri increases oxytocin levels Poutahidis et al., 2013) . Interestingly, we found a reduction in oxytocin-positive neurons in the PVN ( Figure 5A ) of Shank3B À/À mice compared to WT littermates ( Figures 5B and 5C ). The number and fluorescence intensity of NeuN-positive neurons did not change in the PVN of Shank3B À/À mice ( Figures 5B, 5D , and 5F), indicating that the decrease in oxytocin-positive neurons in Shank3B À/À was not due to a decrease in the total number of neurons. As expected, L. reuteri treatment increased both the number and fluorescence intensity of oxytocin-positive neurons in Shank3B À/À mice (Figures 5B, 5C, and 5E) .
Given that L. reuteri treatment promotes oxytocin immunoreactivity in the PVN of Shank3B À/À mice and rescues their social deficits, we hypothesized that oxytocin administration would also reverse the social deficits in Shank3B À/À mice. As predicted, intranasal oxytocin ( Figure 6A ) reversed the social deficits in Shank3B À/À mice (Figures 6B, 6C , and S10A). Moreover, oxytocin improved the social behaviors that are deficient in VPA (Figures S11A and S11B), BTBR mice (Figures S11C-S11E), and partially in GF mice (Figures S11F-S11H), all models in which L. reuteri effectively rescues their social deficits. Interestingly, like L. reuteri treatment, oxytocin had no effect on the hypo-activity behavior in the Shank3B À/À mice (Figures S10B and S10C). Together, these data suggest that oxytocinergic signaling is involved in the mechanism of action by which L. reuteri selectively restores social behavior in several ASD mouse models.
L. reuteri Restores Social Interaction-Induced Synaptic Potentiation in the Ventral Tegmental Area of Shank3B -/-Mice, but Not in Mice Lacking the Oxytocin Receptor in Dopaminergic Neurons Brain regions responding to naturally rewarding stimuli, including the ventral tegmental area (VTA) and the nucleus accumbens (NAc), are crucially involved in social behaviors (Dö len et al., 2013; Gunaydin et al., 2014; Huang and Hessler, 2008) . In addition, oxytocin-expressing neurons in the PVN project to the VTA (Melis et al., 2007) . Oxytocin activates VTA neurons in both mice and humans, influencing the processing of socially relevant cues Intestinal permeability assay by FITC intensity shows no difference between Shank3B À/À mice and WT littermates (n = 6-7 per group; WT + DSS versus WT, t = 3.17, p < 0.05; WT+ DSS versus Shank3B À/À , t = 3.95, p < 0.01; WT versus Shank3B À/À , t = 0.81, p > 0.99; one-way ANOVA, F 2.17 = 8.6, p = 0.0026).
(B) Expression of gut tight junction components was unaltered in Shank3B À/À mice, as determined by RT-qPCR (n = 5-6 per group; WT versus Shank3B À/À , Cdh1 t = 0.17, p > 0.99; Ocln t = 0.13, p > 0.99, Cldn5 t = 1.03, p > 0.99; Jam1 t = 0.87, p > 0.99; one-way ANOVA, F 3,39 = 0.62, p = 0.60).
(C) Schematic of the vagotomy experimental design.
(D-F) In vagotomized Shank3B À/À mice, L. reuteri failed to reverse social behavior deficits in the three-chamber test (D, Sociability, n = 7 per group; Shank3B À/À Sham + L. reuteri, t = 3.22, p < 0.05; Shank3B À/À Vagotomized + L. reuteri, t = 1.33, p = 0.35; two-way ANOVA, F 1,24 = 10,4, p = 0.003; E, Social Novelty, n = 7 per group; Shank3B À/À Sham + L. reuteri, t = 2.56, p < 0.05; Shank3B À/À Vagotomized + L. reuteri: t = 2.60, p < 0.05; two-way ANOVA, F 1,22 = 0.028, p = 0.86) and reciprocal social interaction test (F, n = 6-7 pairs per group; Shank3B À/À Sham + L. reuteri versus Shank3B À/À Vagotomized + L. reuteri, Mann-Whitney Test p < 0.01). DSS, dextran sodium sulfate; ns, not significant. Plots show mean ± SEM. See also Figure S9 . (Gregory et al., 2015; Groppe et al., 2013; Hung et al., 2017; Tang et al., 2014; Xiao et al., 2017) , and oxytocin receptor blockade in the VTA prevents social attachment in rodents (Pedersen et al., 1994) . Moreover, optogenetic stimulation of VTA-NAc projections promotes social interaction (Gunaydin et al., 2014) . Social interaction, which can be particularly rewarding, triggers synaptic potentiation in VTA dopamine (DA) neurons of both birds (Huang and Hessler, 2008) and mice . Since the oxytocinergic system is impaired in Shank3B À/À mice, we hypothesized that social interaction-induced VTA plasticity would be deficient in these mice. To test this hypothesis, we recorded direct social interaction-evoked long-term potentiation (LTP) in VTA DA neurons (Figures 7A and S12A-S12C) by measuring the ratio of alpha-amino-3-hydroxy-5- (C-F) Oxytocin-positive cell number (C, n = 5 mice per group; WT versus Shank3B À/À + vehicle, t = 2.96, p < 0.05; Shank3B À/À + vehicle versus Shank3B À/À + L. reuteri: t = 3.64, p < 0,05; WT versus Shank3B À/À + L. reuteri, t = 0.59, p > 0.99; one-way ANOVA, F 2,12 = 7.28, p = 0.0085) and oxytocin immunofluorescence intensity (E, n = 5 mice per group; WT versus Shank3B À/À + vehicle, t = 5.38, p < 0.001; Shank3B À/À + vehicle versus Shank3B À/À + L. reuteri, t = 4.41, p < 0.01; WT versus Shank3B À/À + L. reuteri, t = 0.96, p = 0.0025; one-way ANOVA, F 2,12 = 16.49, p = 0.0004) are restored after L. reuteri treatment. The number (D, n = 5 mice per group, WT versus Shank3B À/À + vehicle, t = 0.62, p > 0.99; Shank3B À/À + vehicle versus Shank3B À/À + L. reuteri, t = 1.01, p = 0.99, WT versus Shank3B À/À + L. reuteri, t = 0.38, p > 0.99; one-way ANOVA, F 2.12 = 0.52, p = 0.60) and the fluorescence intensity (F, n = 5 mice per group, WT versus Shank3B À/À + vehicle, t = 1.34, p = 0.61; Shank3B À/À + vehicle versus Shank3B À/À + L. reuteri, t = 1.42, p = 0.54; WT versus Shank3B À/À + L. reuteri, t = 0.07, p > 0.99; one-way ANOVA, F 2,12 = 1.27, p = 0.31) of NeuN-positive cells did not change between the groups. ns, not significant. Plots show mean ± SEM.
methyl-4-isoxazolepropionic acid receptor (AMPAR) to N-methyl-d-aspartate receptor (NMDAR) currents, as we previously described .
As we recently reported , reciprocal social interaction increased the AMPAR/NMDAR in VTA DA neurons from control mice (Figure 7B) . By contrast, the same procedure failed to induce synaptic potentiation in Shank3B À/À mice ( Figure 7B ). The inability to induce social interaction-induced synaptic potentiation in Shank3B À/À VTA DA neurons was not due to changes in baseline activity or to the failure to respond to any stimuli. In fact, baseline AMPAR/NMDAR ratios were similar in Shank3B À/À mice and WT littermates ( Figure 7B) , and a single injection of cocaine, which has been shown to increase the AMPAR/NMDAR ratio in VTA DA neurons Ungless et al., 2001 ; Figure S12D ), evoked LTP in VTA DA neurons of Shank3B À/À mice ( Figure 7B) . Thus, the synaptic potentiation associated specifically with social reward is impaired in Shank3B À/À mice. More importantly, we found that L. reuteri rescues the deficits in social interaction-induced VTA plasticity in Shank3B À/À mice ( Figure 7B) . Consistent with the notion that the effect of L. reuteri on social behavior is mediated by oxytocin, intranasal oxytocin administration also rescued the impaired LTP in VTA DA neurons from Shank3B À/À mice ( Figure 7B ). Hence, social interaction-induced synaptic plasticity is impaired in Shank3B À/À mice but restored by treatment with L. reuteri or oxytocin.
Because PVN-VTA oxytocinergic projections are crucially involved in social behaviors (Hung et al., 2017; Xiao et al., 2017) and that L. reuteri and oxytocin restore social interaction-induced plasticity in VTA DA neurons of ASD models (Buffington et al., 2016; Figure 7B ), we wondered whether the effect of L. reuteri on social behavior and related changes in socialinduced plasticity in the VTA depends on oxytocin signaling. To answer this question, we conditionally deleted oxytocin receptors (Oxtr) in DA neurons (see STAR Methods). Deletion of Oxtr in DA neurons in DA-Oxtr À/À mice had no impact on the levels of L. reuteri in the gut ( Figure S13 ). However, compared to control mice, we found that mice lacking Oxtr in DA neurons (DA-Oxtr À/À ) were socially impaired ( Figure 7C ), consistent with a recent report (Hung et al., 2017) .
Strikingly, treatment with either L. reuteri or oxytocin failed to rescue the deficits in social behaviors ( Figure 7C) (B and C) In Shank3B À/À mice, oxytocin improved social behavior deficits in the three-chamber test (B, Sociability, n = 8-10 per group; WT, t = 3.84, p < 0.01; Shank3B À/À + vehicle, t = 0.28, p > 0.99; Shank3B À/À + oxytocin, t = 2.88, p < 0.05; two-way ANOVA, F 2,48 = 2.94, p = 0.06) and reciprocal social interaction test (C, n = 7-9 pairs per group; WT versus Shank3B À/À + vehicle, t = 2.70, p < 0.05; Shank3B À/À + vehicle versus Shank3B À/À + oxytocin, t = 4.02, p < 0.01; WT versus Shank3B À/À + oxytocin, t = 1.45, p = 0.49; one-way ANOVA, F 2,19 = 0.0025).
(D and E) In Shank3B À/À vagotomized mice, oxytocin also improved social behavior deficits in the three-chamber test (D, Sociability, n = 7 per group; Shank3B À/À Vagotomized + L. reuteri, t = 1.35, p = 0.33; Shank3B À/À Vagotomized + oxytocin, t = 2.76, p < 0.05, two-way ANOVA, F 1,24 = 8.46, p = 0.0077) and reciprocal social interaction test (E, n = 5-6 pairs per group; Shank3B À/À Vagotomized + L. reuteri versus Shank3B À/À Vagotomized + oxytocin, Mann-Whitney Test, p < 0.05). ns, not significant. Plots show mean ± SEM. See also Figures S10 and S11.
changes in VTA DA synaptic function in DA-Oxtr À/À mice ( Figure 7D ). By contrast, cocaine was able to induce LTP in VTA DA neurons of DA-Oxtr À/À mice (Figure 7D) , indicating that oxytocin signaling is selectively required for social interaction-induced synaptic plasticity in the reward circuitry. Consistently, administration of the selective oxytocin receptor antagonist L-371,257 to Shank3B À/À mice prevented the prosocial effects associated with L. reuteri treatment ( Figure S14 ). Collectively, these data show that L. reuteri treatment promotes social behaviors and social interaction-mediated synaptic potentiation in an oxytocin-dependent manner.
DISCUSSION
Traditionally, when we think about the etiology and symptomatology of ASD, we think about the brain. However, recent discoveries that gut microbes could modulate brain function and behavior have added a whole new dimension to this classic view. A large body of preclinical literature supports the notion of a bidirectional communication system linking the gut and the brain, known as the gut-microbiota-brain axis (Borre et al., 2014; Sharon et al., 2016; . Foundational studies have shown that GF mice or mice treated with a broad spectrum of antibiotics show behavioral abnormalities, including endophenotypes associated with ASD (Arentsen et al., 2015; Bercik et al., 2011a; Desbonnet et al., 2014; Diaz Heijtz et al., 2011; Leclercq et al., 2017; Neufeld et al., 2011) .
While most of the focus in the ASD field has been on either genetic or environmental factors associated with the disorder, the gut microbiome lies at the interface between the host and its environment. Moreover, GI symptoms and changes in gut microbial composition are common in ASD individuals . Indeed, while some patients with ASD present a decreased Bacteroidetes/Firmicutes ratio (Strati et al., 2017; Tomova et al., 2015) , others show the opposite result (De Angelis et al., 2013; Zhang et al., 2018) . We found that Shank3B À/À mice show no significant difference in abundance of the two phyla, but the BTBR and VPA models show an increased Bacteroidetes/Firmicutes ratio compared to control mice ( Figure S15 ). Hence, like in humans, changes in the Bacteroidetes/Firmicutes ratio may not be a reliable microbial signature associated with ASD-like behaviors, at least in the ASD mouse models studied here. More importantly, experiments in mouse models have shown that gut microbes can modulate endophenotypes traditionally associated with brain-centered disorders, including ASD Hsiao et al., 2013) . Regardless of the initial insult triggering the disorder (genetic or environmental) and the extent of the alterations to the intestinal microbial communities, we found that L. reuteri reverses social deficits in genetic, environmental, and idiopathic models of ASD. Thus, our data (in mice) support the idea that microbial therapies could ameliorate specific endophenotypes associated with ASD. More importantly, while most of the studies in the microbiome field so far have been correlational in nature, where the composition of the microbiota is associated to a particular behavioral or disease state, we began to mechanistically dissect how a particular microbe in the gut impacts brain function and behavior. Our results showing that L. reuteri is able to reverse the social deficits in different mouse models of ASD hold promise for novel therapies in human patients. However, the gut-microbiota-brain axis is an emerging field, and to ensure the success of microbialbased therapies for neurological disorders, we believe that first it would be important to establish a set of defined and objective criteria for transitioning into human clinical trials. We discuss some of these criteria below:
First, it would be important that the bacterial strain(s) restores the behavioral deficits of interest (e.g., social deficits) in multiple models of a disease, demonstrating the robustness of the microbial intervention. Specifically, we have shown that L. reuteri rescues social deficits in several mouse models of ASD, including a genetic model (Shank3B À/À ), three environmental models (VPA, GF, and MHFD; Buffington et al., 2016) , and an idiopathic model (BTBR) of ASD (Figures 1, 2, 3, and S6) . Future experiments to assess whether L. reuteri is also effective in non-mouse models of ASD, such as rats (Harony-Nicolas et al., 2017) or even nonhuman primates (Zhao et al., 2017) , would provide an even stronger rationale for moving toward developing therapies for humans. For instance, studying the effect of L. reuteri in pigs would be revealing, since their GI tract is more similar to that of humans (Zhang et al., 2013) . However, to our knowledge, pig models with social deficits are not currently available.
Second, it will be of great significance to determine whether the effect of the candidate microbe(s) is direct or indirect-that is, whether the microbe itself is driving the effect or instead modulating the abundance and/or function of other members of the microbial community, which in turn affect behavior. If the latter case, it would be key to define which member(s) of the community is the main player(s). This may ultimately determine whether the therapy will be based on only one microbe (monotherapy) or a combination of bacteria (probiotic cocktail; Olson et al., 2018) . Surprisingly, we found that L. reuteri alone is sufficient to reverse the social behavioral deficits in GF mice, demonstrating that its effect on social behavior does not depend on other members of the microbial community (Figure 3) .
Third, there should be a minimal understanding of the mechanism through which the gut microbe of interest modulates behavior. In this regard, we found that the L. reuteri-mediated rescue of social behavior depends on oxytocinergic and dopaminergic reward systems. We and others have previously provided correlational evidence that L. reuteri increases oxytocin levels Poutahidis et al., 2013) , but causal evidence linking L. reuteri and oxytocin signaling during social behavior was missing. Here, we show that L. reuteri reverses the social deficits in several mouse models of ASD ( Figures 1E-1H , 2C-2E, 3B-3D, and S6G), but it fails to do so in mice lacking oxytocin receptor specifically in dopaminergic neurons (DA-Oxtr À/À mice, Figure 7C ). Moreover, in Shank3B À/À mice in which oxytocin receptors were pharmacologically blocked, treatment with L. reuteri was not longer able to reverse the social deficits in these mice (see Figure S14 ). Accordingly, like L. reuteri, oxytocin reverses the social deficits in all of the other ASD mouse models tested (MHFD, VPA, GF, BTBR, and Shank3B À/À mice; see Figures 6 and S11 and Buffington et al., 2016) , but not in DA-Oxtr À/À mice ( Figure 7C ). Thus, our genetic and pharmacological results support the concept that the effect of L. reuteri on social behavior depends on the oxytocinergic systems.
In addition, we have previously found that social interactioninduced LTP in VTA DA neurons was impaired in MHFD mice and that L. reuteri reverses these long-lasting synaptic changes that likely underlie the social deficits . However, it was not clear whether this form of plasticity was also impaired in genetic models of ASD. Here we found that, like the environmental MHFD model, genetic models of ASD (Shank3B À/À and DA-Oxtr À/À ) exhibit impaired social interaction-induced VTA plasticity and social behavior (Figures 1 and  7) , indicating that there may be a convergent cellular and synaptic mechanism underlying the neuropathology associated with ASD. More importantly, treatment with both L. reuteri and oxytocin reverses the social interaction-induced LTP in VTA DA neurons from Shank3B À/À mice, but it fails to do so in DA-Oxtr À/À mice ( Figure 7D) , consistent with the idea that L. reuteri-mediated increase in oxytocin enhances the salience and rewarding value of social stimuli. Accordingly, the release of oxytocin from PVN neurons onto VTA DA neurons increases excitability during social interaction (Hung et al., 2017) . Taken together, these data support the notion that social behavior (and its mechanisms) can be also studied at the cellular level by measuring changes in synaptic plasticity in VTA dopaminergic neurons upon social interaction.
Moreover, our new results identified the main communication channel between the gut and the brain through which L. reuteri improves social behaviors in mouse models of ASD ( Figures  4D-4F ). It has been previously shown that microbes could (B) AMPAR/NMDAR ratio in lateral VTA DA neurons recorded at baseline and 24 hr after reciprocal social interaction (n = 6-8; WT baseline versus Shank3B À/À + vehicle baseline, t = 1.81, p > 0.99; WT baseline versus WT social interaction, t = 5.70, p < 0.0001; WT baseline versus Shank3B À/À + vehicle social interaction, t = 0.29, p > 0.99; WT baseline versus Shank3B À/À + L. reuteri, t = 1.07, p > 0.99; WT baseline versus Shank3B À/À + L. reuteri social interaction, t = 4.04, p < 0.01; WT baseline versus Shank3B À/À + cocaine, t = 3.64, p < 0.05; WT baseline versus Shank3B À/À + oxytocin social interaction, t = 4.29, p < 0.01; Shank3B À/À baseline + vehicle versus WT social interaction, t = 7.51, p < 0.0001; Shank3B À/À + vehicle baseline versus Shank3B À/À + vehicle social interaction, t = 1.58, p > 0.99; Shank3B À/À + vehicle baseline versus Shank3B À/À + L. reuteri, t = 0.66, p > 0.99, Shank3B À/À + vehicle baseline versus Shank3B À/À + L. reuteri social interaction, t = 5.78, p < 0.0001; Shank3B À/À + vehicle baseline versus Shank3B À/À + cocaine, t = 5.38, p < 0.0001; Shank3B À/À + vehicle baseline versus Shank3B À/À + oxytocin social interaction t = 6.1, p < 0.0001; WT social interaction versus Shank3B À/À + vehicle social interaction, t = 6.18, p < 0.0001; WT social interaction versus Shank3B À/À + L. reuteri, t = 6.55, p < 0.0001; WT social interaction versus Shank3B À/À + L. reuteri social interaction, t = 1.43, p > 0.99; WT social interaction versus Shank3B À/À + cocaine, t = 1.83, p > 0.99; WT social interaction versus Shank3B À/À + oxytocin social interaction, t = 1.41, p > 0.99; Shank3B À/À + vehicle social interaction versus Shank3B À/À + L. reuteri, t = 0.82, p > 0.99; Shank3B À/À + vehicle social interaction versus Shank3B À/À + L. reuteri social interaction, t = 4.44, p < 0.01; Shank3B À/À + vehicle social interaction versus Shank3B À/À + cocaine, t = 4.03, p < 0.01; Shank3B À/À + vehicle social interaction versus Shank3B À/À + oxytocin social interaction, t = 4.72, p < 0.001; Shank3B À/À + L. reuteri versus Shank3B À/À + L. reuteri social interaction, t = 4.93, p < 0.001; Shank3B À/À + L. reuteri versus Shank3B À/À + cocaine, t = 4.55, p < 0.01; Shank3B À/À + L. reuteri versus Shank3B À/À + oxytocin social interaction, t = 5.19, p < 0.001; Shank3B À/À + L. reuteri social interaction versus Shank3B À/À + cocaine, t = 0.38, p > 0.99; Shank3B À/À + L. reuteri social interaction versus Shank3B À/À + oxytocin social interaction, t = 0.07, p > 0.99; Shank3B À/À + cocaine versus Shank3B À/À + oxytocin social interaction, t = 0.47, p > 0.99; one-way ANOVA, F 7,46 = 16.68, p < 0.0001). Representative AMPA and NMDA traces are shown above each group. (C) Reciprocal social interaction was impaired in DA-Oxtr À/À mice, and neither L. reuteri or oxytocin reversed the social deficits in these mice (n = 10-12 pairs per group; Controls versus DA-Oxtr À/À + vehicle, t = 6.095, p < 0.0001; Controls versus DA-Oxtr À/À + L. reuteri, t = 5.517, p < 0.0001; Controls versus DA-Oxtr À/À + oxytocin, t = 5.148, p < 0.0001; DA-Oxtr À/À + vehicle versus DA-Oxtr À/À + L. reuteri, t = 0.6059, p > 0.99; DA-Oxtr À/À + vehicle versus DA-Oxtr À/À + oxytocin, t = 0.8639, p > 0.99; DA-Oxtr À/À + L. reuteri versus DA-Oxtr À/À + oxytocin, t = 0.2712, p > 0.99; one-way ANOVA, F 3,41 = 15.34, p < 0.0001). (D) AMPA/NMDA ratio of DA neurons in the lateral VTA at baseline and 24 hr after reciprocal social interaction (n = 6-7 per group; DA-Oxtr À/À + vehicle social interaction versus DA-Oxtr À/À social interaction + L. reuteri, t = 0.02, p > 0.99; DA-Oxtr À/À + vehicle social interaction versus Controls baseline, t = 0.40, p > 0.99; DA-Oxtr À/À + vehicle social interaction versus DA-Oxtr À/À + cocaine, t = 5.47, p < 0.0001; DA-Oxtr À/À + vehicle social interaction versus DA-Oxtr À/À + vehicle, t = 0.44, p > 0.99, DA-Oxtr À/À + vehicle social interaction versus Controls social interaction, t = 4.92, p < 0.001; DA-Oxtr À/À + vehicle social interaction versus DA-Oxtr À/À + oxytocin social interaction, t = 0.089, p > 0.99; DA-Oxtr À/À + L. reuteri social interaction versus Controls baseline, t = 0.37, p > 0.99; DA-Oxtr À/À + L. reuteri social interaction versus DA-Oxtr À/À + cocaine, t = 5.49, p < 0.0001; DA-Oxtr À/À + L. reuteri social interaction versus DA-Oxtr À/À + vehicle, t = 0.47, (legend continued on next page) modulate anxiety and depression-related behaviors via the vagus nerve (Bercik et al., 2011b; Bravo et al., 2011) . Moreover, a recent report shows that optogenetic stimulation of the vagal gut-to-brain axis modulates reward-related behavior (Han et al., 2018) , indicating that the vagus nerve connects the gut to the brain reward system. Coincidetally, we found that changes in the gut microbiome could influence long-lasting changes in synaptic efficacy in the mesolimbic dopamine reward system underlying social behaviors (Figure 7 and Buffington et al., 2016) . In addition, here we provide new evidence that the vagus nerve is a central gut-brain communication pathway by which L. reuteri promote social behavior ( Figures 4D-4F) . While bacteria can interact with the vagus nerve via intrinsic primary afferent neurons (Perez-Burgos et al., 2014) , further studies are necessary to investigate how precisely L. reuteri interacts with the vagus nerve. For instance, according to a recent report, cells from the gastrointestinal tract with a primarily endocrine function (enterodocrine cells) form synapses with vagal afferents (Kaelberer et al., 2018) . It would be interesting to examine whether L. reuteri signals to the brain via alteration of the enterodocrine cell function or specifically by promoting synaptic function between these cells and vagal afferents.
Lastly, given that vagus nerve stimulation, like L. reuteri treatment, increases oxytocin levels (Stock and Uvn€ as-Moberg, 1988 ) and transcutaneous vagus nerve stimulation enhances facial emotion recognition in humans (Sellaro et al., 2018) , it would be interesting to examine in future experiments whether selective stimulation of vagal afferents improves social behaviors.
Fourth, to corroborate the validity of the microbial-based therapy, the effect of the probiotic treatment on behavior should be reproduced by other laboratories. Indeed, consistent with our results, an independent study by Tabouy et al. (2018) has recently found that L. reuteri successfully corrects social deficits in Shank3B À/À mice.
Finally, the microbial treatment must be safe and long-lasting in humans. While probiotics are generally believed to be safe, safety assessments (e.g., toxicity, genetic stability, and potential pathogenicity) of the microbial treatment of interest need to be performed. Accordingly, in terms of safety, an L. reuteri strain used in infants (Indrio et al., 2014) has received a certification of Generally Recognized as Safe (GRAS) for use in humans by the FDA. Moreover, when compared to (1) the transient effect on behavior associated with intranasal administration of oxytocin Peñ agarikano et al., 2015) , (2) the high amount of intranasal oxytocin needed to effective improve behavior in humans (Leng and Ludwig, 2016) , and (3) the potential risk of oxytocin receptor desensitization (Robinson et al., 2003) associated with the long-term administaration of high dose of oxytocin, L. reuteri emerges an intriguing non-inva-sive therapeutic alternative to persistently increase ''endogenous'' oxytocin levels in the brain. Therefore, in view of the robust and consistent reversal of social behavioral deficits by L. reuteri in several ASD mouse models and its safety profile, it would be interesting to examine whether L. reuteri is able to improve social behavior in individuals with ASD in future studies.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: p > 0.99; DA-Oxtr À/À + L. reuteri social interaction versus Controls social interaction: t = 4.94, p < 0.001; Controls baseline versus DA-Oxtr À/À + cocaine, t = 6.08, p < 0.0001; Controls baseline versus DA-Oxtr À/À + vehicle, t = 0.88, p > 0.99; Controls baseline versus Controls social interaction, t = 5.50, p < 0.0001; Controls baseline versus DA-Oxtr À/À + oxytocin social interaction, t = 0.32, p > 0.99; DA-Oxtr À/À + cocaine versus DA-Oxtr À/À + vehicle, t = 5.23, p < 0.001; DA-Oxtr À/À + cocaine versus Controls social interaction, t = 0.55, p > 0.99; DA-Oxtr À/À + cocaine versus DA-Oxtr À/À + oxytocin social interaction, t = 5.76, p < 0.0001; DA-Oxtr À/À + vehicle versus Controls social interaction, t = 4.66, p < 0.001; DA-Oxtr À/À + vehicle versus DA-Oxtr À/À + oxytocin social interaction, t = 0.55, p > 0.99; Controls social interaction versus DA-Oxtr À/À + oxytocin social interaction, t = 5.19, p < 0.001; one-way ANOVA, F 6,38 = 13.46, p < 0.0001). ns, not significant. Plots show mean ± SEM. See also Figures S12-S14. 
METHOD DETAILS
16S rRNA Gene Sequencing 16S rRNA gene sequencing was performed as previously described . Methods were adapted from protocols provided for the NIH-Human Microbiome Project (Methé et al., 2012; Human Microbiome Project Consortium, 2012) . Bacterial genomic DNA was extracted using MO BIO PowerSoil DNA Isolation Kit (MO BIO Laboratories). The 16S rDNA V4 region was amplified by PCR and sequenced in the MiSeq platform (Illumina) using the 2x250 bp paired-end protocol yielding pair-end reads that overlap almost completely. The primers used for amplification contain adapters for MiSeq sequencing and single-end barcodes allowing pooling and direct sequencing of PCR products. The 16S rRNA gene read pairs were demultiplexed based on the unique molecular barcodes, and reads were merged using USEARCH v7.0.1090 (Edgar, 2010) , allowing zero mismatches and a minimum overlap of 50 bases. Merged reads were trimmed at first base with Q5. A quality filter was applied to the resulting merged reads. Reads containing above 0.05 expected errors were discarded. 16S rRNA gene sequences were clustered into Operational Taxonomic Units (OTUs) at a similarity cutoff value of 97% using the UPARSE algorithm (Edgar, 2013) . OTUs were mapped to an optimized version of the SILVA Database (Quast et al., 2013) resources table) .
Culture and Treatment with L. reuteri Lactobacillus reuteri MM4-1A (ATCC-PTA-6475) was cultured aerobically in MRS broth at 37 C. Briefly, cultures were centrifuged, washed, resuspended in phosphate buffered saline (PBS), and frozen at À80 C until use. PBS (vehicle) or L. reuteri were added to the drinking water daily to minimize dosage variability. The experimental group received live bacteria ($1x10 8 organisms/mouse/day), while the control group received equal volume of PBS. Mice consumed the treated water ad libitum for the duration of the treatment period. Fecal sample collection, behavioral assays, tissue collection and electrophysiological recordings were initiated 4 weeks after treatment began.
Three Chamber Social Test
All behavioral tests were assayed on 7-to 10-week-old male mice. Social behaviors were performed as previously described Silverman et al., 2010) . Briefly, mice were first habituated for a 10 minutes in an empty 60 3 40 3 23 cm Plexiglass arena divided into three interconnected chambers (left, center, right). Sociability was evaluated during a second 10-minutes period in which the subject could interact either with an empty wire cup (Empty) or a wire cup containing a genotype, age, sex and treatmentmatched stranger conspecific (Mouse 1). The interaction time was determined by measuring the time the subject mouse spent sniffing or climbing upon either the empty cup or the cup containing the stranger mouse. The position of the empty cup/stranger mouse in the left or right chamber during the sociability period was counterbalanced between trials, in order to avoid bias. Preference for social novelty was assayed, in a third 10 minutes period, by introducing a second stranger mouse (Mouse 2) into the previously the empty wire cup. The time spent interacting with the empty cup or mouse 1 or mouse 2 was recorded and measured using the automated AnyMaze software by trained, independent observers. The human observers were blind to the treatment group.
Reciprocal Social Interaction
Mice were placed in a 25 3 25 3 25 cm Plexiglass neutral arena with an unfamiliar conspecific matched according genotype, age, sex and treatment. Trained, independent observers recorded the time a pair of mice socially interacted, using the AnyMaze software. This included close following, touching, nose-to-nose sniffing, nose-to-anus sniffing, grooming and/or crawling over/under each other. The human observers were blind to the treatment group.
Open Field
Mice were placed in an open arena (40 3 40 3 20 cm) and allowed to explore freely for 10 minutes and their position was continually monitored using the tracking software AnyMaze. Distance traveled, speed, and time spent in the center of the arena were recorded and automatically measured throughout the task. The center of the arena was defined as the interior 20 3 20 cm area.
Buried Food Test
To examine olfactory abilities we used the buried food test as previoiulsy described (Yang and Crawley, 2009 ). Briefly, mice were food-deprived for 24 hr before the test. A small platable cookie (Nabisco, Teddy Graham) was buried 1 cm beneath the surface of a 3 cm bedding and the time the animal took to locate the buried cookie was recorded. Faillure to use odor cues to locate the buried food during this test is an indication of impaired olfaction.
Bilateral Subdiaphragmatic Vagotomy
Mice were habituated to a liquid diet (35% sweetened condensed milk in water) for two days before surgery and fasted overnight before surgery. Anesthesia was delivered by gaseous isoflurane (Henry Schein Animal Health) in an induction chamber and then through a nose piece of the stereotaxic apparatus (Leica Biosystems). The surgical site was shaved and wiped with betadine and alcohol three times before a midline laparotomy was made. The liver and small intestine were gently retracted to visualize the stomach and lower esophagus. Both vagus nerve trunks were dissected off the esophagus and all neural and connective tissue surrounding the esophagus (below the diaphragm) were removed to ensure that all vagus branches were transected. A separate group of mice had a sham operation in which the vagus nerve was visualized, but not dissected. Incisions were closed with 5-0 absorbable suture (i.e., vicryl on a taper needle) and the skin was closed with a non-absorbable suture 5-0 on a cutting needle (i.e., Nylon or prolene) to re-approximate the abdominal wall musculature and skin. Histoacryl or similar surgical glue was applied over the incision to ensure that the closure was watertight. Sustained release buprenorphine (1mg/kg) was administered 1 hr prior to the start of surgery. A second dose of sustained release buprenorphine was administered subcutaneously at 72 hr after the initial dosing. After the surgery was complete, animals were allowed to recover from surgery and anesthesia in a clean cage half-positioned on a heat pad and returned to the animal facility after they were alert and demonstrated no complications from the procedure. In order to avoid ileus, the mice were fed with the same liquid diet for 3 days after surgery. Finally, before giving the mice the regular pellet diet, they were fed with a fully fortified gel diet (DietGel 31M, ClearH 2 O) for two days in order to facilitate a full recovery. Animals were monitored daily for at least 1 week to ensure complete recovery from surgery.
To assess the completeness of the vagotomy we performed the satiety test. Satiety induced by CCK-8 is mediated by the vagus nerve (Owyang and Heldsinger, 2011) . The completeness of the vagotomy was determined by analyzing the satiety effect induced by CCK-8 (Sigma-Aldrich) administration, following 20 hr of food deprivation. Briefly, mice were fasted overnight. The following day sham operated and vagotomized mice were single housed and treated with an intraperitoneal injection (i.p.) of CCK-8 (dissolved in 0.1% PBS) at a dose of 8 mg/kg body weight (Bravo et al., 2011) . Food intake was monitored for the following 2 hr, by weighing food pellets pre-and post-test. The completeness of the vagotomy was made at the end of the experiment, at least two weeks after the final treatment dose, since probiotics have been shown to influence the satiety effect of CCK-8 (Få k and B€ ackhed, 2012; Falcinelli et al., 2016) .
amplitudes of the isolated components were used to calculate the AMPAR/NMDAR ratios. Cocaine hydrochloride (Sigma-Aldrich, St. Louis, MO) was dissolved in 0.9% saline and injected I.P. at a volume of 5 ml/kg 24 hr prior to electrophysiological recordings.
Statistical Analysis
Statistical analysis was performed as described . Data were presented as mean ± SEM. Statistical analyses performed include Mann-Whitney test, one-or two-way ANOVA with Bonferroni post hoc analysis to correct for multiple comparisons, unless otherwise indicated. p, t, and F values were presented in the figure legends. p < 0.05 was considered statistically significant. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. GraphPad's Prism 6 (La Jolla, CA) software was used to perform statistical analyses and generate graphical data representations. As per 16S rRNA gene sequencing, analysis was conducted in RStudio 0.99.292 (http://www.R-project.org/ [2014]), utilizing the phyloseq package (McMurdie and Holmes, 2013) to import sample data and calculate alpha and beta-diversity metrics. 16S rRNA gene sequencing data was analyzed using Silva 115 and 123 (Quast et al., 2013) . Analyses were performed on datasets that were rarefied 1,000x, then averaged and rounded. Significance of categorical variables were determined using the non-parametric Mann-Whitney test for two category comparisons or the Kruskal-Wallis test when comparing three or more categories. Correlation between two continuous variables was determined by linear regressions, where p values indicate the probability that the slope of the regression line is zero. Principal coordinate plots employed the Monte Carlo permutation test to estimate p values. All p values were adjusted for multiple comparisons with the FDR algorithm (Benjamini et al., 2001) .
